<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00867555</url>
  </required_header>
  <id_info>
    <org_study_id>MEC 08-3-052</org_study_id>
    <nct_id>NCT00867555</nct_id>
  </id_info>
  <brief_title>Green Tea, High in Epigallocatechin Gallate (EGCG) and Postprandial Fat Oxidation</brief_title>
  <official_title>Effects of the Green Tea Extract TEAVIGO High in EGCG, on Postprandial Fat Oxidation in Overweight Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DSM Nutritional Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The body of evidence regarding the health benefits of green tea has grown considerably during&#xD;
      the last decade and includes antioxidant properties, anti- cancer, anti-obesity and&#xD;
      anti-diabetes effects. There has been evidence that green tea extract favorably affect body&#xD;
      weight and body fat and has positive effects on blood glucose control&#xD;
&#xD;
      Aim of this study is to investigate the short term effect (3-day)of TEAVIGO (high in the&#xD;
      catechin EGCG) on postprandial fat oxidation during different phases of the postprandial&#xD;
      period in overweight subjects. Secondly, in a subset of volunteers changes in lipolysis and&#xD;
      glucose metabolism will be studied in skeletal muscle and adipose tissue.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postprandial fat oxidation</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Obesity</condition>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>EGCG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Double blind randomized, placebo-controlled cross-over design with two arms:&#xD;
the green tea extract TEAVIGO, high in EGCG and&#xD;
placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Effect of the green tea extract TEAVIGO, high in EGCG, on postprandial fat oxidation</intervention_name>
    <description>green tea extract TEAVIGO, high in EGCG</description>
    <arm_group_label>EGCG</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 20 and 50 y&#xD;
&#xD;
          -  BMI 25.0-29.9 kg/m2&#xD;
&#xD;
          -  Normal fasting glucose &lt;6.1 mmol/L&#xD;
&#xD;
          -  Blood pressure (systolic blood pressure 100-150 mmHg, diastolic blood pressure 60-90&#xD;
             mmHg)&#xD;
&#xD;
          -  Weight stable in last 3 months (Â±2 kg)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant, lactating or (post)menopausal women&#xD;
&#xD;
          -  regular smokers&#xD;
&#xD;
          -  people with intensive fitness training eg athletes&#xD;
&#xD;
          -  habitual consumption of green or black tea (more than 1 or 2 cups a day, respectively)&#xD;
&#xD;
          -  not more than 300 mg/day caffeine consumption&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ellen E Blaak, PhD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept Human Biology, Maastricht University</name>
      <address>
        <city>Maastricht</city>
        <zip>6200 MD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <study_first_submitted>March 23, 2009</study_first_submitted>
  <study_first_submitted_qc>March 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2009</study_first_posted>
  <last_update_submitted>September 17, 2009</last_update_submitted>
  <last_update_submitted_qc>September 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Ellen E Blaak, Prof</name_title>
    <organization>Maastricht University</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

